Status:
UNKNOWN
Enhanced Versus Extended Preoperative Antibiotic Prophylaxis Regimens for Retrograde Intrarenal Surgery in High Infectious Risk Patients
Lead Sponsor:
Mansoura University
Conditions:
Renal Stone
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
In the available literature, there is a lack the risk categorization of infectious complications after RIRS with subsequent recommendation as regard to AP in different risk patients. Therefore this st...
Detailed Description
Retrograde intrarenal surgery (RIRS) has gained a wide popularity in the management of renal stones due to tremendous technological advancements over the last years. According to the current guideline...
Eligibility Criteria
Inclusion
- Ability to give informed consent.
- Age ≥18 years.
- Renal stone \<20 mm in which RIRS is recommended.
- High susceptibility of post-procedural infectious complications by one or more of the followings: - Positive preoperative urine culture within 12 weeks of the planned intervention. -Indwelling ureteral stents for more than 4 weeks. -Diabetes mellitus.
Exclusion
- Solitary kidney.
- Chronic kidney disease.
- Pregnant.
- Have received antibiotics within 7 days prior to enrollment.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2023
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT05384197
Start Date
May 1 2022
End Date
July 1 2023
Last Update
November 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura Urology and Nephrology Center
Al Mansurah, Outside U.S./Canada, Egypt, 35516